<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01781858</url>
  </required_header>
  <id_info>
    <org_study_id>Scope-001</org_study_id>
    <nct_id>NCT01781858</nct_id>
  </id_info>
  <brief_title>Study on the Clinical Course Of Pulmonary Embolism</brief_title>
  <acronym>SCOPE</acronym>
  <official_title>Study on the Clinical Course Of Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padua</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padua</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The course of both pulmonary embolism (PE) and one of its more relevant late complications,
      i.e. chronic thromboembolic pulmonary hypertension (CTEPH) is still substantially unknown.

      Recent evidence has shown that the incidence of CTEPH is higher than previously believed, but
      this has not been confirmed by other studies. A clear link between PE and CTEPH has been
      questioned by some experts. A great number of patients affected by PE persistently have
      residual chronic thromboembolic material the meaning of which is a matter of debate. The
      evidence sustaining a link between chronic residual PE and subsequent PE recurrences or CTEPH
      is insufficient.

      Thus, a nationwide, multicentre, prospective cohort study was designed with the following
      aims:

        1. to ascertain the incidence of symptomatic CTEPH after a first episode of acute PE;

        2. to ascertain the incidence of venous thromboembolic (VTE) recurrences after a first
           episode of acute PE;

        3. to evaluate whether a relation exists between chronic residual PE and CTEPH

        4. to evaluate whether a relation exists between chronic residual PE and VTE recurrences;

        5. to evaluate whether a relation exists between persistent right ventricular dysfunction
           and CTEPH;

        6. to evaluate whether a relation exists between persistent right ventricular dysfunction
           and PE recurrences.

      For each enrolling centre, consecutive outpatients or inpatients with an objectively
      diagnosed first acute PE episode are considered eligible.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients enrolled in the study received a diagnosis of PE by means of chest CT scan, lung
      scanning or pulmonary angiography. All patients should undergo an echocardiographic
      examination during the acute phase of PE, when this is possible. All patients will be treated
      according to current international guidelines and local protocols. All surviving patients
      will receive an echocardiographic examination after 6 weeks and 6 months. All surviving
      patients will receive a perfusional pulmonary scintigraphy at 6 months and be subsequently
      followed up every 6 months for at least 3 years.

      In case of clinical suspicion of VTE recurrence a diagnostic procedure will be performed in
      order to confirm the recurrent VTE episode ( Chest CT scan, lung scan, Pulmonary angiography,
      compressive ultrasound, phlebography, vein CT scan).

      In case of clinical suspicion of CTEPH, a further diagnostic workup will be performed,
      consisting in echocardiography, ventilation/perfusion lung scanning, multidetector chest CT
      scanning, and pulmonary angiography, with direct measurement of the pulmonary-artery
      pressure.

      The extension of pulmonary embolism during the acute phase will be graded according to a
      standardized scoring system by local investigators while the extension of chronic residual
      pulmonary embolism will be graded according to a standardized scoring system ( Meyer score)
      by both local investigators and an independent committee. All outcome events will be
      centrally adjudicated by an independent committee.

      All clinical data ( initial data on medical history, clinical symptoms, presence of risk
      factors, diagnoses, diagnostic tests results, treatment type and duration, outcome events and
      other) will be collected by the local investigators in an electronic medical database.
      Related data will be sent to the coordinating centre on a regular basis. All recruiting
      centres will be regularly monitored by the coordinating Centre.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of chronic thromboembolic pulmonary hypertension</measure>
    <time_frame>within 3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of recurrent venous thromboembolic events</measure>
    <time_frame>within 3 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of all-cause mortality</measure>
    <time_frame>within 3 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Pulmonary Embolism - related mortality</measure>
    <time_frame>within 3 years</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">700</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Venous Thromboembolism</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>pulmonary embolism</arm_group_label>
    <description>Consecutive outpatients and inpatients with first episode of acute pulmonary embolism</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive outpatients or inpatients with an objective diagnosis of first acute PE
        episode.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive Outpatients/Inpatients with acute first episode of acute pulmonary
             embolism

        Exclusion Criteria:

          -  Pregnancy

          -  Age &lt; 18 years

          -  expected survival &lt; 2 years

          -  previous episodes of VTE

          -  need for anticoagulation for reasons other than VTE

          -  preexisting severe cardiac or pulmonary diseases

          -  preexisting diseases that could cause non thromboembolic pulmonary hypertension

          -  Patients geographically inaccessible for follow up

          -  Low compliance to anticoagulant therapy and planned diagnostic work-up

          -  Refusal to give written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raffaele Pesavento, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Padua</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paolo Prandoni, MD,PHD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Padua</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Pagnan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Padua</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gualtiero Palareti, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bologna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Palla, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Pisa, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vittorio Pengo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Padua</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franco Piovella, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Pavia - Italy</affiliation>
  </overall_official>
  <reference>
    <citation>Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 May 27;350(22):2257-64.</citation>
    <PMID>15163775</PMID>
  </reference>
  <reference>
    <citation>Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006 Jul;130(1):172-5.</citation>
    <PMID>16840398</PMID>
  </reference>
  <reference>
    <citation>Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013 Feb;41(2):462-8. doi: 10.1183/09031936.00049312. Epub 2012 Jun 14. Review.</citation>
    <PMID>22700839</PMID>
  </reference>
  <reference>
    <citation>Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007 Feb;92(2):199-205.</citation>
    <PMID>17296569</PMID>
  </reference>
  <reference>
    <citation>Verso M, Agnelli G, Ageno W, Imberti D, Moia M, Palareti G, Pistelli R, Cantone V; MASTER investigators. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry. Thromb Res. 2012 Sep;130(3):369-73. Epub 2012 May 13.</citation>
    <PMID>22583838</PMID>
  </reference>
  <reference>
    <citation>Cosmi B, Nijkeuter M, Valentino M, Huisman MV, Barozzi L, Palareti G. Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism. Intern Emerg Med. 2011 Dec;6(6):521-8. doi: 10.1007/s11739-011-0577-8. Epub 2011 Apr 3.</citation>
    <PMID>21461909</PMID>
  </reference>
  <reference>
    <citation>Alhadad A, Miniati M, Alhadad H, Gottsäter A, Bajc M. The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism. Thromb Res. 2012 Dec;130(6):877-81. doi: 10.1016/j.thromres.2012.09.002. Epub 2012 Sep 29.</citation>
    <PMID>23026380</PMID>
  </reference>
  <reference>
    <citation>Poli D, Miniati M. The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism. Curr Opin Pulm Med. 2011 Sep;17(5):392-7. doi: 10.1097/MCP.0b013e328349289a. Review.</citation>
    <PMID>21743331</PMID>
  </reference>
  <reference>
    <citation>Poli D, Grifoni E, Antonucci E, Arcangeli C, Prisco D, Abbate R, Miniati M. Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism. J Thromb Thrombolysis. 2010 Oct;30(3):294-9. doi: 10.1007/s11239-010-0452-x.</citation>
    <PMID>20157841</PMID>
  </reference>
  <reference>
    <citation>Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, Dainelli A, Giuntini C. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 2006 Sep;85(5):253-62.</citation>
    <PMID>16974210</PMID>
  </reference>
  <reference>
    <citation>Nijkeuter M, Söhne M, Tick LW, Kamphuisen PW, Kramer MH, Laterveer L, van Houten AA, Kruip MJ, Leebeek FW, Büller HR, Huisman MV; Christopher Study Investigators. The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. Chest. 2007 Feb;131(2):517-23.</citation>
    <PMID>17296656</PMID>
  </reference>
  <reference>
    <citation>Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest. 2006 Jan;129(1):192-7. Review.</citation>
    <PMID>16424432</PMID>
  </reference>
  <reference>
    <citation>Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.</citation>
    <PMID>21969018</PMID>
  </reference>
  <reference>
    <citation>Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost. 2012 Jun;18(3):281-8. doi: 10.1177/1076029611431956. Epub 2012 Jan 23.</citation>
    <PMID>22275389</PMID>
  </reference>
  <reference>
    <citation>Wilkens H, Lang I, Behr J, Berghaus T, Grohe C, Guth S, Hoeper MM, Kramm T, Krüger U, Langer F, Rosenkranz S, Schäfers HJ, Schmidt M, Seyfarth HJ, Wahlers T, Worth H, Mayer E. Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011 Dec;154 Suppl 1:S54-60. doi: 10.1016/S0167-5273(11)70493-4.</citation>
    <PMID>22221974</PMID>
  </reference>
  <reference>
    <citation>Willemink MJ, van Es HW, Koobs L, Morshuis WJ, Snijder RJ, van Heesewijk JP. CT evaluation of chronic thromboembolic pulmonary hypertension. Clin Radiol. 2012 Mar;67(3):277-85. doi: 10.1016/j.crad.2011.09.012. Epub 2011 Nov 25. Review.</citation>
    <PMID>22119298</PMID>
  </reference>
  <reference>
    <citation>Ley S, Ley-Zaporozhan J, Pitton MB, Schneider J, Wirth GM, Mayer E, Düber C, Kreitner KF. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. 2012 Mar;22(3):607-16. doi: 10.1007/s00330-011-2290-4. Epub 2011 Sep 27.</citation>
    <PMID>21947513</PMID>
  </reference>
  <reference>
    <citation>Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2011 Jan 27;364(4):351-60. doi: 10.1056/NEJMra0910203. Review.</citation>
    <PMID>21268727</PMID>
  </reference>
  <reference>
    <citation>Martí D, Gómez V, Escobar C, Wagner C, Zamarro C, Sánchez D, Sam A, Briongos S, Gaudó J, Sueiro A, Jiménez D. [Incidence of symptomatic and asymptomatic chronic thromboembolic pulmonary hypertension]. Arch Bronconeumol. 2010 Dec;46(12):628-33. doi: 10.1016/j.arbres.2010.07.012. Spanish.</citation>
    <PMID>20926172</PMID>
  </reference>
  <reference>
    <citation>Surie S, Gibson NS, Gerdes VE, Bouma BJ, van Eck-Smit BL, Buller HR, Bresser P. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res. 2010 May;125(5):e202-5. doi: 10.1016/j.thromres.2009.12.016. Epub 2010 Jan 20.</citation>
    <PMID>20085846</PMID>
  </reference>
  <reference>
    <citation>Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010 Jun;95(6):970-5. doi: 10.3324/haematol.2009.018960. Epub 2010 Jan 6.</citation>
    <PMID>20053871</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2013</study_first_submitted>
  <study_first_submitted_qc>January 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2013</study_first_posted>
  <last_update_submitted>June 13, 2016</last_update_submitted>
  <last_update_submitted_qc>June 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Padua</investigator_affiliation>
    <investigator_full_name>Raffaele Pesavento</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Pulmonary embolism</keyword>
  <keyword>Chronic thromboembolic pulmonary hypertension</keyword>
  <keyword>Venous thromboembolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

